In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Doximity Inc’s stock clocked out at $24.58, down -0.85% from its previous closing price of $24.79. In other words, the price has decreased by -$0.85 from its previous closing price. On the day, 1.36 million shares were traded. DOCS stock price reached its highest trading level at $25.155 during the session, while it also had its lowest trading level at $24.555.
Ratios:
To gain a deeper understanding of DOCS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.46 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.61. For the most recent quarter (mrq), Quick Ratio is recorded 7.97 and its Current Ratio is at 7.97. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on February 26, 2024, initiated with a Market Perform rating and assigned the stock a target price of $32.
On January 03, 2024, Barclays started tracking the stock assigning a Equal Weight rating and target price of $31.
BofA Securities Upgraded its Underperform to Neutral on January 02, 2024, whereas the target price for the stock was revised from $21 to $29.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 01 ’24 when Wampler Kira Scherer sold 2,500 shares for $26.97 per share. The transaction valued at 67,425 led to the insider holds 10,258 shares of the business.
Wampler Kira Scherer sold 2,500 shares of DOCS for $69,700 on Mar 01 ’24. The Director now owns 10,258 shares after completing the transaction at $27.88 per share. On Feb 16 ’24, another insider, Overpeck Craig, who serves as the insider of the company, sold 1,500 shares for $30.02 each. As a result, the insider received 45,030 and left with 112,971 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DOCS now has a Market Capitalization of 4585497088 and an Enterprise Value of 3890309120. As of this moment, Doximity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 37.04, and their Forward P/E ratio for the next fiscal year is 25.88. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.79 while its Price-to-Book (P/B) ratio in mrq is 5.29. Its current Enterprise Value per Revenue stands at 8.307 whereas that against EBITDA is 22.898.
Stock Price History:
Over the past 52 weeks, DOCS has reached a high of $37.06, while it has fallen to a 52-week low of $19.71. The 50-Day Moving Average of the stock is -10.47%, while the 200-Day Moving Average is calculated to be -6.52%.
Shares Statistics:
It appears that DOCS traded 1.69M shares on average per day over the past three months and 1427210 shares per day over the past ten days. A total of 120.68M shares are outstanding, with a floating share count of 117.86M. Insiders hold about 36.83% of the company’s shares, while institutions hold 49.65% stake in the company. Shares short for DOCS as of 1711584000 were 9133225 with a Short Ratio of 5.41, compared to 1709164800 on 7364506. Therefore, it implies a Short% of Shares Outstanding of 9133225 and a Short% of Float of 8.6899996.
Earnings Estimates
A detailed examination of Doximity Inc (DOCS) is currently in progress, with 15.0 analysts providing valuable insights into its market dynamics.On average, analysts expect EPS of $0.2 for the current quarter, with a high estimate of $0.22 and a low estimate of $0.14, while EPS last year was $0.2. The consensus estimate for the next quarter is $0.21, with high estimates of $0.25 and low estimates of $0.18.
Analysts are recommending an EPS of between $0.92 and $0.87 for the fiscal current year, implying an average EPS of $0.9. EPS for the following year is $0.95, with 14.0 analysts recommending between $1.03 and $0.87.
Revenue Estimates
In the current quarter, 15 analysts expect revenue to total $116.4M. It ranges from a high estimate of $116.76M to a low estimate of $115.2M. As of the current estimate, Doximity Inc’s year-ago sales were $110.97MFor the next quarter, 15 analysts are estimating revenue of $119.23M. There is a high estimate of $126.8M for the next quarter, whereas the lowest estimate is $114M.
A total of 17 analysts have provided revenue estimates for DOCS’s current fiscal year. The highest revenue estimate was $474.12M, while the lowest revenue estimate was $473M, resulting in an average revenue estimate of $473.84M. In the same quarter a year ago, actual revenue was $419.05MBased on 17 analysts’ estimates, the company’s revenue will be $520.95M in the next fiscal year. The high estimate is $526.06M and the low estimate is $514.37M.
